DEV — Deversify Health AB (publ) Cashflow Statement
0.000.00%
- SEK12.78m
- SEK12.77m
- SEK18.66m
Annual cashflow statement for Deversify Health AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 0.494 | -12.6 | -22.9 | -20.9 |
| Non-Cash Items | -0.284 | 4.29 | 7.26 | 17.4 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.644 | 0.62 | 0.677 | -0.484 |
| Change in Accounts Receivable | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 0.855 | -7.7 | -14.9 | -4.02 |
| Capital Expenditures | -0.958 | -4.51 | -1.27 | -1.25 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -0.012 | 0.039 | -0.021 | 0.408 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.971 | -4.47 | -1.29 | -0.847 |
| Financing Cash Flow Items | — | — | — | -0.001 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.238 | 23.5 | 8.88 | 2.34 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.354 | 11.3 | -7.34 | -2.52 |